IDO1 and neoplasm: When mice bearing established Lewis lung carcinomas were treated with synthetic cyclic di-adenyl monophosphate (CDA) to activate STING, a rapid increase in immune regulatory pathways was observed involving PD-1, IDO and COX-2 in the tumor micro-environment [208].